Close Menu
    What's Hot

    Washington State finds its rhythm in impressive win over Hawaii

    November 19, 2026

    3 Oregon State Basketball Players to Watch Against Oregon

    November 19, 2026

    Supporting Cast Guides Auburn Basketball to Win Over UNLV in Players Era 8

    November 19, 2026
    Facebook X (Twitter) Instagram Threads
    TheBullPost
    Facebook X (Twitter) Instagram
    Subscribe
    • International
    • Politics
    • Crime
    • Economy
    • Sports
    • Entertainment
      • Music
      • Movie
      • Gaming
      • Literature
    • continents
      • Africa
      • America
      • Asia
      • Australia
      • Europe
    • Tech
    • Top Trending
    • Editor’s Pick
    • Lifestyle
      • Fashion
      • food
      • Health
      • Travel
    TheBullPost
    Home»International»Discontinuation of muscular dystrophy drug in Canada intensifies need for alternative drug not yet funded in B.C.
    International

    Discontinuation of muscular dystrophy drug in Canada intensifies need for alternative drug not yet funded in B.C.

    soreceryBy soreceryNovember 18, 2026No Comments5 Mins Read
    Share
    Facebook Twitter Pinterest Threads Bluesky Copy Link
    Lochlan
    Lochlan Booth, 5, and his mom Leanna Booth of Comox Valley. Lochlan has Duchenne, a rare form of muscular dystrophy. They are hoping the B.C. government will fund a treatment called vamorolone after it was announced the only other stable treatment is being discontinued in Canada. Photo by Leanna Booth

    Article content

    A drug used to treat a rare form of muscular dystrophy will no longer be sold in Canada, leaving some B.C. families anxious about their children’s’ futures as an alternative drug is far more expensive and not yet funded by the province.

    View more offers

    Article content

    Duchenne muscular dystrophy, a rare genetic disorder that weakens the muscles and usually targets boys, is treated with a corticosteroid drug called Calcort (deflazacort). But the German company that manufactures the drug says it will discontinue it in Canada because of manufacturing and supply chain issues.

    Article content

    Article content

    Advertisement 1

    Story continues below

    This advertisement has not loaded yet, but your article continues below.

    Article content

    Xediton Pharmaceuticals, the Canadian distributor of deflazacort, says existing inventory is estimated to last until the spring, Defeat Duchenne Canada recently announced. The national charity says it is working with Health Canada to explore potential alternative sources of the drug and the regulatory steps needed to support access.

    Article content

    Sunrise presented by Vancouver Sun Banner

    Sunrise

    Start your day with a roundup of B.C.-focused news and opinion.

    By signing up you consent to receive the above newsletter from Postmedia Network Inc.

    Thanks for signing up!

    A welcome email is on its way. If you don’t see it, please check your junk folder.

    The next issue of Sunrise will soon be in your inbox.

    We encountered an issue signing you up. Please try again

    Article content

    Health Canada recently approved an alternative steroid drug called vamorolone, but it hasn’t been approved for funding in B.C. Vamorolone is very expensive, costing $131,400 a year, according to Canada’s Drug Agency, compared to just over $1,000 a year for deflazacort.

    Article content

    Leanna Booth, a Comox Valley resident, said her five-year-old son Lochlan has been receiving vamorolone through a federal program that grants special access to a drug undergoing approval.

    Article content

    When “Locky” was three years old, he began falling down all the time. The family had him tested and eventually learned he had Duchenne. He was put on deflazacort, which helped stop him from falling down, but caused what Booth described as dreadful mood swings.

    Article content

    Lochlan
    Five-year-old Lochlan Booth of Comox Valley. Lochlan has Duchenne, a rare form of muscular dystrophy. His parents are hoping the B.C. government will fund a drug that could prolong his ability to walk. Photo by Leanna Booth

    Article content

    Within a week of being on vamorolone, the mood swings stopped and he didn’t fall down.

    Article content

    Advertisement 2

    Story continues below

    This advertisement has not loaded yet, but your article continues below.

    Article content

    So now the family is stressed because if deflazacort is taken away as an option, and vamorolone isn’t funded, then they won’t have access to a stable steroid treatment, which they need him to be on to take part in clinical trials for other treatments.

    Article content

    Read More

    1. Kasha Mitton with her husband Jeff and son Jude. Jude has a rare genetic disease called Duchenne muscular dystrophy. The Kamloops family is calling for a national strategy for rare disease so they can access approved treatment faster.

      B.C. mother of boy with muscular dystrophy calls for rare disease strategy

    2. In the 2024-2025 fiscal year, spending on expensive drugs for rare diseases was just under $200 million, according to the B.C. government. Photo by Chanintorn.v /Getty Images

      No fixes yet for costly rare disease drug program, one year after David Eby called for changes

    3. Advertisement 1

      Story continues below

      This advertisement has not loaded yet, but your article continues below.

    Article content

    With Duchenne, muscles weaken day by day. Booth said they know Lochlan will eventually need a wheelchair, but vamorolone could prolong the time he has to walk.

    Article content

    “It will give him more time to be a kid, and more time to ride a bike, and more time to just stay on his feet and walk around and play sports,” she said.

    Article content

    “Even if it gives him just a few more years, it would be life-changing for him.”

    Article content

    With deflazacort expected to run out in the spring, the Booth family is pleading with the B.C. government to speed up the approval process and fund vamorolone.

    Article content

    “It’s so frustrating watching this approval and funding process go so slow. You’re watching your boy thinking, ‘How much longer do you have to walk? Will this be available and accessible to us before you lose your ability to walk?’”

    Article content

    Booth family
    The Booth family of Comox Valley on Vancouver Island. Their son, five-year-old Lochlan, has Duchenne, a rare form of muscular dystrophy. They are hoping a life-changing drug will be approved for funding by the B.C. government. Photo by Leanna Booth

    Article content

    A much cheaper steroid drug called prednisone is also available, but it comes with horrible side effects, such as weight gain, mood changes and sleep issues, said Kasha Mitton, a Kamloops mother whose 14-year-old son Jude has Duchenne.

     

    Share this:

    • Share on X (Opens in new window) X
    • Share on Facebook (Opens in new window) Facebook

    Like this:

    Like Loading…
    Share. Facebook Twitter Pinterest Bluesky Threads Tumblr Telegram Email
    Unknown's avatar
    sorecery
    • Website

    Related Posts

    Compromise and collegiality: How the dynamics of Vancouver’s new city council are playing out in first meetings

    November 18, 2026

    Police name victims of Walmart parking lot shooting in Surrey

    November 18, 2026

    Four Maryland high school students sue after AI mistakes Doritos bag for gun

    November 18, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Economy News

    Washington State finds its rhythm in impressive win over Hawaii

    By soreceryNovember 19, 2026

    ​ EVERETT, Wash. — For all the talk by third-year coach David Riley, and for…

    Share this:

    • Share on X (Opens in new window) X
    • Share on Facebook (Opens in new window) Facebook

    Like this:

    Like Loading…

    3 Oregon State Basketball Players to Watch Against Oregon

    November 19, 2026

    Supporting Cast Guides Auburn Basketball to Win Over UNLV in Players Era 8

    November 19, 2026
    Top Trending

    Washington State finds its rhythm in impressive win over Hawaii

    By soreceryNovember 19, 2026

    ​ EVERETT, Wash. — For all the talk by third-year coach David…

    Share this:

    • Share on X (Opens in new window) X
    • Share on Facebook (Opens in new window) Facebook

    Like this:

    Like Loading…

    3 Oregon State Basketball Players to Watch Against Oregon

    By soreceryNovember 19, 2026

    ​ Riding a 5-0 start that’s been fueled by electric offensive play,…

    Share this:

    • Share on X (Opens in new window) X
    • Share on Facebook (Opens in new window) Facebook

    Like this:

    Like Loading…

    Supporting Cast Guides Auburn Basketball to Win Over UNLV in Players Era 8

    By soreceryNovember 19, 2026

    ​ Coming off a late-night loss to West Virginia under 24 hours…

    Share this:

    • Share on X (Opens in new window) X
    • Share on Facebook (Opens in new window) Facebook

    Like this:

    Like Loading…
    Advertisement
    TheBullPost
    • About
    • Privacy Policy
    • Contact us
    • Terms of Service: The Bull Post
    © 2026 The Bull Post. Designed by Sorecery.

    Type above and press Enter to search. Press Esc to cancel.

    %d